$48.98 $0.46 (0.9%)

04:00 PM EDT on 08/21/19

CRISPR Therapeutics (NASDAQ:CRSP)

CAPS Rating: 4 out of 5

Current Price $48.98 Mkt Cap $2.0B
Open $49.18 P/E Ratio 0.00
Prev. Close $48.52 Div. (Yield) $0.00 (0.0%)
Daily Range $48.51 - $49.89 Volume 418,996
52-Wk Range $27.15 - $53.90 Avg. Daily Vol.

Caps

How do you think NASDAQ:CRSP will perform against the market?

Add Stock to CAPS Watchlist

All Players

115 Outperform
4 Underperform
 

All-Star Players

39 Outperform
2 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:CRSP Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:CRSP VS S&P 500 (SPY)

NASDAQ:CRSP Summary

Fools bullish on NASDAQ:CRSP are also bullish on:

Fools bearish on NASDAQ:CRSP are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CRSP.

Recs

0
Member Avatar SurfingCabarete (49.12) Submitted: 7/9/2019 12:17:33 PM : Outperform Start Price: $47.69 NASDAQ:CRSP Score: +4.17

pure gamble on gene editing

Recs

0
Member Avatar MaestroFool (83.27) Submitted: 6/8/2019 2:40:17 PM : Outperform Start Price: $35.79 NASDAQ:CRSP Score: +32.68

The name says it all: a super long-term play in gene editing CRISPR/CAS9 technology. I couldn't say if this stock is going to beat the market this or next year or the year after that (although it has been a market beater thusfar for me here on CAPS) but this is such an interesting and important company that it's worth keeping track of here and again, long-term, I think could be a tremendous multi-bagger. For now, it's a sliver of my portfolio.

Recs

0
Member Avatar nbowser (< 20) Submitted: 5/13/2019 1:32:38 AM : Outperform Start Price: $39.90 NASDAQ:CRSP Score: +19.22

a strong quarter with earnings reported on 5/13 will result in pop and stock will beat bear market.

Leaderboard

Find the members with the highest scoring picks in CRSP.

Score Leader

CMFMLove

CMFMLove (43.51) Score: +227.53

I'm generally bad at CAPS but I may have gotten this pick right. There's a long way to go, however, until we see commercial results from this technology.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
CMFMLove 43.51 6/13/2017 Outperform 5Y $14.10 +247.38% +19.85% +227.53 1 Comment
Momentum21 86.20 10/24/2016 Outperform 5Y $14.05 +248.61% +36.14% +212.47 0 Comment
Playa14 < 20 6/9/2017 Outperform 5Y $15.13 +223.73% +19.80% +203.93 0 Comment
prankjt17530 48.75 2/13/2017 Outperform 5Y $15.21 +222.02% +26.00% +196.03 0 Comment
SHOPNVDA < 20 6/26/2017 Outperform 5Y $16.84 +190.86% +19.89% +170.97 0 Comment
Capitalism 84.82 5/15/2017 Outperform 5Y $17.05 +187.27% +21.78% +165.50 1 Comment
TMFFishBiz 49.84 11/13/2017 Outperform 5Y $17.91 +173.48% +13.21% +160.27 0 Comment
JF9383 67.82 12/6/2017 Outperform 5Y $18.44 +165.62% +11.24% +154.38 0 Comment
jeepdrew222 65.13 12/12/2017 Outperform 5Y $18.61 +163.19% +9.69% +153.50 0 Comment
odocoileus < 20 10/5/2017 Outperform 5Y $19.05 +157.11% +15.33% +141.78 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CRSP.